Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Research Reports > Hematology Diagnostics Market to Garner US$5,586.4 Million by 2026 at 5.0% CAGR | Finds TMR
    Research Reports

    Hematology Diagnostics Market to Garner US$5,586.4 Million by 2026 at 5.0% CAGR | Finds TMR

    Published by TMR Research Insights

    Posted on September 30, 2021

    4 min read

    Last updated: February 1, 2026

    Image of Kim Leadbeater addressing the media about proposed changes to the UK's assisted dying law, emphasizing the removal of High Court judge sign-off to enhance the legislative process.
    Lawmaker Kim Leadbeater discusses UK's assisted dying law changes - Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Quick Summary

    The hematology diagnostics market is expected to grow to $5.6 billion by 2026, driven by technological advancements and rising blood disorder cases.

    Hematology Diagnostics Market to Reach $5.6 Billion by 2026

    The vendor landscape of the global market of hematology diagnostics features a handful of companies collectively accounting for a large share in the overall market, hinting at a largely consolidated vendor landscape, observes Transparency Market Research in a recent report. Companies such as Sysmex Corporation, Abbott Laboratories, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd. command dominance owing to their expansive product portfolios and well-established distribution channels globally.

    Read Report Overview – https://www.transparencymarketresearch.com/hematology-diagnostics-market.html

    To gain a larger hold on the market through more diverse product portfolios as compared to their peers, companies are resorting to strategic partnerships. Case in point is Abbott’s October 2017 acquisition of Alere Inc., a leading diagnostic services and device provider. Other leading companies in the market are Siemens Healthineers, Bio-Rad Laboratories, Inc., Danaher (Beckman Coulter, Inc.), Mindray Medical International Limited, HemoCue AB, and HORIBA, Ltd.

    According to the report, the global hematology diagnostics market will exhibit a healthy 5.0% CAGR over the period between 2018 and 2026. The market had a valuation of approximately US$3,495.0 mn in 2017 and is anticipated to rise to a revenue opportunity of US$5,586.4 mn by 2026.

    Request a PDF Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8848

    Europe and North America to Remain Leading Revenue Contributors to Global Market

    Geographically, the markets in Europe and North America are presently the leading contributors of revenue to the global market, chiefly owing to the high prevalence of blood disorders, high awareness regarding available screening methods for blood-related conditions, and high expenditure on healthcare and wellness.

    Of the key hematology instruments examined in the report, the segment of hematology analyzers presently accounts for the dominant share in the overall market, thanks to the increased adoption of fully-automated hematology analyzers for more accurate results and reduced turnaround times.

    Request for Analysis of COVID19 Impact on Hematology Diagnostics Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=8848

    Rising Global Prevalence of Blood Cancer to Drive Need for Effective Diagnostic Measures

    The chief factor to have helped the global hematology diagnostics market achieve vast stride in terms of technological advancements and introduction of new product varieties at a steady pace in the recent years is the vast rise in focus on the effective diagnosis of the rising cases of blood disorders in developed as well as developing economies. Studies show that blood cancers such as leukemia, lymphoma, or myeloma affected nearly 172,910 people in the U.S. alone in 2017. Cases diagnosed with these cancers are likely to have held a nearly 10% share in the estimated 1,688,780 new cancer cases diagnosed in the country in 2017.

    Moreover, nearly 1,290,773 people are either in the remission form or are living with myeloma, leukemia, or lymphoma in U.S. Increased awareness and understanding regarding these conditions among healthcare professionals as well as patients have also led to the increased adoption of hematology diagnostics devices over the years.

    Buy Hematology Diagnostics Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=8848&ltype=S

    Apart from this, the increased adoption of point-of-care-testing methods, technological advancements leading to more accurate results and easy-to-use devices, and the easy availability of a vast range of tests are also likely to drive the hematology diagnostics market. However, the market could face headwinds in the form of low awareness among population in developing economies and the high cost of advanced and automated instruments.

    More Trending Reports by Transparency Market Research –

    Viral Vector & Plasmid DNA Manufacturing Market: https://www.prnewswire.com/news-releases/global-viral-vector–plasmid-dna-manufacturing-market-to-chart-23-3-cagr-from-2019-to-2027-transparency-market-research-301000176.html

    Viscosupplementation Market: https://www.prnewswire.com/news-releases/rising-number-of-osteoporosis-cases-boosts-demand-avenues-in-viscosupplementation-market-says-transparency-market-research-301312591.html

    About Us

    Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

    TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

    Contact

    Transparency Market Research
    USA – Canada Toll Free: 866-552-3453
    Email: sales@transparencymarketresearch.com
    Blog: https://tmrblog.com/
    Follow Us: Twitter | LinkedIn
    Press Release Source: https://www.transparencymarketresearch.com/pressrelease/hematology-diagnostics-market.htm

    Key Takeaways

    • •Global hematology diagnostics market projected to reach $5.6 billion by 2026.
    • •Key players include Sysmex, Abbott, and Beckman Coulter.
    • •Europe and North America lead in market revenue.
    • •Rising blood cancer cases drive demand for diagnostics.
    • •Technological advancements improve diagnostic accuracy.

    Frequently Asked Questions about Hematology Diagnostics Market to Garner US$5,586.4 Million by 2026 at 5.0% CAGR | Finds TMR

    1What is the main topic?

    The article discusses the growth of the hematology diagnostics market, projected to reach $5.6 billion by 2026.

    2Who are the key players in the market?

    Key players include Sysmex Corporation, Abbott Laboratories, and Beckman Coulter, Inc.

    3What regions are leading in market revenue?

    Europe and North America are the leading revenue contributors to the global market.

    More from Research Reports

    Explore more articles in the Research Reports category

    Image for Workflow Automation Market Outlook 2025: Business Expansion, Market Trends, and Future Predictions
    Workflow Automation Market Outlook 2025: Business Expansion, Market Trends, and Future Predictions
    Image for Smart Contracts Market 2032 Industry Overview, Evolution Growth Rate and Future Forecasts 2025-2032
    Smart Contracts Market 2032 Industry Overview, Evolution Growth Rate and Future Forecasts 2025-2032
    Image for Predictive Maintenance Market 2025-2032: Industry Outlook, Trends Analysis, New Opportunities, and Prospects
    Predictive Maintenance Market 2025-2032: Industry Outlook, Trends Analysis, New Opportunities, and Prospects
    Image for Oilseed Market to Expand at a CAGR of 5.3% by 2032 – Growth Drivers & Forecast Analysis
    Oilseed Market to Expand at a CAGR of 5.3% by 2032 – Growth Drivers & Forecast Analysis
    Image for Offshore Decommissioning Market Predicted to Reach USD 12.27 Billion by 2032, Growing at a CAGR of 6.3% | Coherent Market Insights
    Offshore Decommissioning Market Predicted to Reach USD 12.27 Billion by 2032, Growing at a CAGR of 6.3% | Coherent Market Insights
    Image for Flea And Tick Products Market Anticipated to flourish at a CAGR of 9.32% from 2025 to 2032
    Flea And Tick Products Market Anticipated to flourish at a CAGR of 9.32% from 2025 to 2032
    Image for Customer Data Platform Market Growth Probability, Key Vendors and Future Scenario Up To 2032
    Customer Data Platform Market Growth Probability, Key Vendors and Future Scenario Up To 2032
    Image for Carbon Dioxide Utilization Market to Hit $14.38 Bn by 2032 with a CAGR of 13.6% According to Coherent Market Insights
    Carbon Dioxide Utilization Market to Hit $14.38 Bn by 2032 with a CAGR of 13.6% According to Coherent Market Insights
    Image for Beauty Supplements Market Anticipated to flourish at a CAGR of 5.55% from 2025 to 2032, reaching USD 4,591 Million by 2032
    Beauty Supplements Market Anticipated to flourish at a CAGR of 5.55% from 2025 to 2032, reaching USD 4,591 Million by 2032
    Image for AI Governance Market Size & Forecast 2025-2032 : Emerging Business Opportunities and Growth Prospects
    AI Governance Market Size & Forecast 2025-2032 : Emerging Business Opportunities and Growth Prospects
    Image for Wireline Services Market to Reach USD 47.13 Billion by 2032 with a 7.0% CAGR According to Coherent Market Insights
    Wireline Services Market to Reach USD 47.13 Billion by 2032 with a 7.0% CAGR According to Coherent Market Insights
    Image for U.S. Hospitality Staffing Market to be Worth USD 258.72 Billion by 2032: Coherent Market Insights
    U.S. Hospitality Staffing Market to be Worth USD 258.72 Billion by 2032: Coherent Market Insights
    View All Research Reports Posts
    Previous Research Reports PostAnkle Replacement Market Witness Stunning Growth By 2028 | Waldemar Link Gmbh&Co.KG, Small Bone Innovation, Integra LifeSciences Holdings Corporation
    Next Research Reports PostErythropoietin Drugs Market Value Predicted To Reach US$ 21 Billion By 2031 | Explosive Report by insightSLICE